Looking back at the first half of 2022, the pharmaceutical sector performed poorly overall. The MSCI China Healthcare Index fell by 33% in 1H22, underperforming the broader market, as the MSCI China Index declined by 18% over the same period. Structural opportunities remain in the second half of the year:
On one hand: As the world enters the post-pandemic era, “normalization” has become the new theme of epidemic prevention and control globally. Amid recurrent outbreaks and continuously expanding demand for medical services, the healthcare industry as a whole is experiencing rapid development.
Amid the uncertainties of the pandemic, the general public has become increasingly attentive to their health, shifting from “seeking medical care only when ill” to “preventing disease before it occurs,” and from “clinical medical devices” to “home-use medical devices.” Healthcare services have gradually integrated into daily life, prompting numerous enterprises to vie for position in the healthcare sector.
On the other hand: In the long term, the pharmaceutical sector remains a promising growth trajectory. Driven by population aging and the continuous advancement of biotechnology, the industry exhibits sustained long-term growth potential. With policy directions remaining stable, fundamentals maintaining optimistic growth, and geopolitical risks having manageable actual impacts—coupled with the sector’s current valuation still at historically low levels—the pharmaceutical industry shows considerable investment potential for the second half of the year.
To this end, on June 17, the Preparatory Committee for the Boda Yuanzhi Future Technology Medical Forum will kick off its mid-year live streaming extravaganza. The event has invited numerous highly influential industry leaders and investors to focus on investment opportunities in the pharmaceutical sector in the post-pandemic era and the pathways to the rise of new brands. Additionally, renowned TCM experts and professors have been specially invited to share insights on health and wellness practices on-site. Stay tuned!
Preparatory Committee for the Broad Yuan Future Technology Medical Forum
June 16, 2022
1. Livestream Details
First Half:"La Zhangzhang: The Accumulated Strength and Persistent Commitment of Healthy Food and Beverage Products"
Host:Chen Yunru, Head of Human Resources at New South Group
Special Guests:
Wang Xinhua, Former President and Professor of Guangzhou Medical University
Wang Nan Co-President of Yuanzhi Technology Medical
Wang Yuegui, Deputy General Manager of Deng Lao Jin Fang Pharmaceutical Technology Group Co., Ltd.
Part II: "Seizing the Moment: Supply and Demand Release in the Post-Pandemic Era and Golden Tracks"
Time: 16:10-17:10
Yang Mohan, Chief of Boda Healthcare Investment; Investment Director at Yuanzhi Healthcare
Featured Guest:
Gao Yibo, Chief Scientist of the National Key Research and Development Program;
Director, Translational Medicine Laboratory, National Clinical Research Center for Malignant Tumors
Yi Lin, Partner at Defu Capital
Xu Qian, Partner at Danlu Capital (General Manager, Beijing Office)
2. How to Watch the Live Broadcast
1) Xiaoe-Tech Live Streaming
Please scan the QR code to reserve your spot in advance; you will receive a reminder before the live broadcast begins:

2) WeChat Channels Live Stream, Reserve Now:

On June 17 at 15:00, scan the QR code to reserve your spot in the live broadcast. We look forward to seeing you there!
3. Watch the live stream to unlock double benefits
Benefit 1: Watch the live stream for a chance to win surprise gifts
【Boda x Yuanzhi】 Mid-Year Major Livestream: Exclusive perks await, including the co-branded Deng Lao Qingguan Yin set. Lucky draws will be held during the livestream—don’t miss out!
Benefit 2: Exclusive Protection Plan for New Product Launches
To support public health, the “Deng Lao Qing Guan Yin Co-Branded Edition,” jointly launched by Deng Lao Jin Fang, Yuanzhi Health, and Zhujiang Life Insurance, will soon be available on major e-commerce platforms. Each co-branded set includes two boxes, each with its own unique QR code. Upon successful purchase, customers can scan the code to redeem a complimentary Yuanzhi Health service package and Zhujiang Life Insurance coverage of up to RMB 500,000.
